LOGIN JOIN SHARECAFE SIGN UP FOR OUR NEWSLETTER ADVERTISE
share cafe logo  
 
SHARECAFE SHARES ARCHIVE

ARTICLES BY DATE


You Are Viewing Page 6 Of 548  1 2 3 4 5 6 7 8 9 10 11

Monday, January 29 2018

     › NHF - Morgans rates as Hold
     › Stephen Koukoulas - Inflation Data In Focus
     › Dollar Confusion Lifts Commodities
     › Bulls Keep Charging Ahead In US Market
     › Lid Still On Oz Inflation
     › Diary: State of the Union, Yellen's Farewell, Local Inflation
     › Can The FAANGs Sustain Their Momentum?
     › Oil Holds Firm As US Rig Count Jumps Higher
     › Monday At The Open

Friday, January 26 2018

     › Yield and Risk

Thursday, January 25 2018

     › Marcus Today End Of Day Report
     › Thursday At The Close
     › 2018 - A List Of Lists Regarding The Macro Investment Outlook
     › Turbulence Hits Buffett's Airline Bets
     › The New Criterion: From Bitcoin To Blockchain
     › High Tech Lithium & Cobalt Explorers Leading The Charge
     › Market At Midday On Thursday
     › 7 Bitcoin Alternatives
     › Next Week At A Glance
     › Forget Bitcoin, Cobalt Is The Hottest Sector
     › Overnight: The Dollar Debate
     › LNK - Citi rates the stock as Buy
     › AMP - Morgan Stanley rates the stock as Equal-weight
     › STO - UBS rates the stock as Sell
     › US Dollar Continues Slide
     › Japanese Trade Booms In 2017
     › Michael Hill Eyes US Exit
     › Higher Prices Spark Santos Revival
     › Strong Christmas Sales See Kathmandu Upgrade
     › Thursday At The Open

Wednesday, January 24 2018

     › Marcus Today End Of Day Report
     › Wednesday At The Close
     › How Much Upside Is There For ResMed?
     › Price Disruption Not Critical For InvoCare
     › Market At Midday On Wednesday
     › Why Trump Is Easing Banking Restrictions
     › Aussie Economy Strengthening?
     › Overnight: Netflicked
     › CAT - Morgans rates the stock as Add
     › NEW - Morgan Stanley rates the stock as Equal-weight
     › RMD - UBS rates the stock as Buy
     › Revenue Jump Sees Resmed On The Rise
     › QBE Stumbles Into New Reset
     › Amcil Echoes Valuation Challenge
     › PNG LNG Lifts Oil Search
     › A.P. Eagers Sales Growth Hits The Brakes
     › Wednesday At The Open

Tuesday, January 23 2018

     › Marcus Today End Of Day Report
     › Tuesday At The Close
     › Bond Yields For Direct Bond Investors
     › If The VIX Is Low, Is It Time To Go?
     › Market At Midday On Tuesday
     › Get Ready For The Next Gold Bull Market
     › Overnight: Open For Business
     › TWE - UBS rates the stock as Upgrade to Buy
     › EHL - Morgans rates the stock as Add
     › DHG - Morgan Stanley rates the stock as Overweight
     › Netflix Adds A Record 8 Million Subscribers
     › AFIC "Waiting For Better Prices"
     › Lid To Come Off Lithium Production?
     › Domain Boss Quits, McGrath's Mass Resignations
     › Aust Pharma Warns On Weaker First-Half
     › Tuesday At The Open

Monday, January 22 2018

     › Marcus Today End Of Day Report
     › Monday At The Close
     › Australian Listed Real Estate Tables
     › Market At Midday On Monday
     › Why Bitcoin Is Uninvestable
     › First Home Buyers Hit Five-Year High
     › CBA - Citi rates the stock as Downgrade to Sell
     › SYD - Morgans rates the stock as Upgrade to Add
     › WPL - UBS rates the stock as Buy
     › Stephen Koukoulas - European Central Bank
     › Metals End Week Mixed
     › Quintis Tumbles Into Administration

You Are Viewing Page 6 Of 548  1 2 3 4 5 6 7 8 9 10 11
  CONTRIBUTORS

James Dunn


David Bassanese


Shane Oliver


Alan Kohler


Barry Fitzgerald


Tim Boreham


Greg Tolpigin


Karl Siegling


Gavin Wendt


Roger Montgomery


Andrew Winter


 
 

RECENTLY ADDED TO SHARECAFE


 › Marcus Today End Of Day Report
 › Friday At The Close
 › James Grant
 › Fixed Income Strategies For 2018
 › Market At Midday On Friday
 › What Is The Risk Of A US Recession?
 › Glencore Chief Feeds Copper Bulls
 › Woolies Gains Ground In Grocery War
 › Next Week At A Glance
 › Where Have The Profits Gone?
 › Finding Out The Truth About Stocks
 › LNK - Citi rates the stock as Buy
 › MOC - Macquarie rates the stock as Underperform
 › ARF - Morgan Stanley rates the stock as Overweight
More ShareCafe   

GET THE SHARECAFE BREAKFAST BRIEFING


Delivered free to your inbox before the market opens each trading day. Sign up below +

SHARECAFE VIDEO


View More Videos